112 related articles for article (PubMed ID: 1898191)
1. [The comparative pharmacokinetics of ceftriaxone in the blood and bronchial secretion in patients with different durations in the course of chronic bronchitis].
Kamnev IuV; Manuĭlov KK; Orlov VA
Antibiot Khimioter; 1991 Jun; 36(6):48-50. PubMed ID: 1898191
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
[TBL] [Abstract][Full Text] [Related]
3. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary penetration of ceftazidime.
Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of ceftibuten in bronchial secretions.
Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
[TBL] [Abstract][Full Text] [Related]
6. The intravitreal penetration of ceftriaxone in man following systemic administration.
Sharir M; Triester G; Kneer J; Rubinstein E
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2179-83. PubMed ID: 2793358
[TBL] [Abstract][Full Text] [Related]
7. Dirithromycin concentrations in bronchial mucosa and secretions.
Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis.
Geny F; Costa P; Bressolle F; Galtier M
Biopharm Drug Dispos; 1993 Mar; 14(2):161-9. PubMed ID: 8453025
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline concentrations in lung tissue, bronchial wall, and bronchial secretions.
Gartmann J
Chemotherapy; 1975; 21 Suppl 1():19-26. PubMed ID: 1157579
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative study of the origin of proteins in the bronchial secretion of patients with chronic obstructive bronchitis].
Szabó S; Rasche B; Módy E; Iazigian A; Száva-Szabó A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):77-84. PubMed ID: 2847304
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
12. [Diffusion of ceftriaxone in bronchial secretions for 24 hours after a single injection].
Gehanno P; Pangon B; Moisy N
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):725-6. PubMed ID: 3309804
[TBL] [Abstract][Full Text] [Related]
13. [Biochemistry of bronchial secretion during chronic bronchitis].
Köhler H
Bronches; 1971; 21(6):529-46. PubMed ID: 5155114
[No Abstract] [Full Text] [Related]
14. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.
Thompson AB; Bohling T; Payvandi F; Rennard SI
J Lab Clin Med; 1990 Feb; 115(2):148-58. PubMed ID: 2299262
[TBL] [Abstract][Full Text] [Related]
15. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
[TBL] [Abstract][Full Text] [Related]
16. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
[TBL] [Abstract][Full Text] [Related]
17. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
Nonikov VE; Konstantinova TD; Makarova OV; Manziuk EN; Minaev VI; Ritchik LA
Ter Arkh; 1997; 69(10):84-8. PubMed ID: 9471801
[TBL] [Abstract][Full Text] [Related]
18. [Free concentration and protein binding of ceftriaxone].
Saionji K; Miyake N; Miyake K; Igari J; Kobayashi I; Satoh Y
Jpn J Antibiot; 1992 Feb; 45(2):136-42. PubMed ID: 1613966
[TBL] [Abstract][Full Text] [Related]
19. Penetration of ceftriaxone into the intervertebral disc.
Lang R; Folman Y; Ravid M; Bental T; Gepstein R
J Bone Joint Surg Am; 1994 May; 76(5):689-91. PubMed ID: 8175816
[TBL] [Abstract][Full Text] [Related]
20. [Short-term prophylaxis with ceftriaxone in planned intrathoracic operations].
Vyhnánek F; Lochmann O; Fanta J
Rozhl Chir; 1994 Nov; 73(7):328-30. PubMed ID: 7817250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
